In the final episode of our three-part series with Jill Fikowski, founder and CEO of Changemark Research + Evaluation, we get into one of the most persistent problems in clinical research: retention.
Jill unpacks why participants drop out and it's rarely what sponsors assume. From there, we get into the pressure that lands on research coordinators when enrollment is behind, the practices that pressure produces. We also look at what happens after the last visit particularly in psychedelic trials and whether researchers have a responsibility that doesn't end when the database closes.
Retention problems, Jill argues, are almost always inception problems. And solving them starts with a question most teams never ask.
Part 3 of 3.
Fler avsnitt av Innovating Clinical Trials
Visa alla avsnitt av Innovating Clinical TrialsInnovating Clinical Trials med Liam Eves and Ted Trafford finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
